LEUKAEMIA PLASMACYTIC side effect
What is LEUKAEMIA PLASMACYTIC ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
LEUKAEMIA PLASMACYTIC and Recently Reported Side Effects
LEUKAEMIA PLASMACYTIC and 15 most Active Side Effect polls
LEUKAEMIA PLASMACYTIC and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Velcade Side Effects Report #5615688-7
Physician from SPAIN reported VELCADE problem on Jan 22, 2008. Female patient, child -1 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient died.
Velcade Side Effects Report #5591256-0
VELCADE problem was reported by a Physician from UNITED STATES on Jan 02, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma, pneumonia, . VELCADE dosage: unknown. During the same period patient was treated with REVLIMID, ZOMETA. Patient died on 06/02/2007.
Zometa Side Effects Report #5536938-1
Consumer or non-health professional from UNITED STATES reported ZOMETA problem on Dec 03, 2007. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic, multiple myeloma, pneumonia, . ZOMETA dosage: unknown. During the same period patient was treated with REVLIMID, VELCADE. Patient was hospitalized. Patient died on 06/02/2007.
Revlimid Side Effects Report #5484505-0
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma, renal failure, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 09/27/2007.
Velcade Side Effects Report #5488962-5
Physician from SPAIN reported VELCADE problem on Oct 02, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic, . VELCADE dosage: 1.30 MG/M2. Patient died.
Velcade Side Effects Report #5488963-7
VELCADE problem was reported by a Physician from SPAIN on Oct 02, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: leukaemia plasmacytic, . VELCADE dosage: 1.30 MG/M2. Patient died.
Revlimid Side Effects Report #5657998-3
Health Professional from UNITED STATES reported REVLIMID problem on Feb 29, 2008. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: dialysis, leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma, pneumonia, renal failure chronic, . REVLIMID dosage: 15 MG, DAILY X21 DAYS, ORAL. During the same period patient was treated with VELCADE, DOXIL. Patient died on 02/09/2008.
Velcade Side Effects Report #5488950-9
VELCADE problem was reported by a Physician from SPAIN on Oct 02, 2007. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: disease progression, leukaemia plasmacytic, . VELCADE dosage: 1.30 MG/M2. Patient died.
Revlimid Side Effects Report #5493992-3
Physician from UNITED STATES reported REVLIMID problem on Oct 16, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, leukaemia plasmacytic, multiple myeloma, renal failure, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 09/27/2007.
Revlimid Side Effects Report #5388775-9
REVLIMID problem was reported by a Physician from UNITED STATES on July 06, 2007. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, leukaemia plasmacytic, multiple myeloma, pneumonia, . REVLIMID dosage: 25 MG, QD 2 ON, 1 OFF, ORAL. During the same period patient was treated with VELCADE, ZOMETA. Patient was hospitalized. Patient died on 06/02/2007.
Revlimid Side Effects Report #5388775-9
Physician from UNITED STATES reported REVLIMID problem on July 06, 2007. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, leukaemia plasmacytic, multiple myeloma, pneumonia, . REVLIMID dosage: 25 MG, QD 2 ON, 1 OFF, ORAL. During the same period patient was treated with VELCADE, ZOMETA. Patient was hospitalized. Patient died on 06/02/2007.
Revlimid Side Effects Report #5776074-2
REVLIMID problem was reported by a Physician from SWITZERLAND on June 09, 2008. Female patient, 61 years of age, was diagnosed with leukaemia plasmacytic, multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, leukaemia plasmacytic, multiple myeloma, . REVLIMID dosage: unknown. Patient died.
Revlimid Side Effects Report #5756909-X
Health Professional from UNITED STATES reported REVLIMID problem on May 20, 2008. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: dialysis, leukaemia plasmacytic, malignant neoplasm progression, multiple myeloma, pneumonia, renal failure chronic, . REVLIMID dosage: 15 MG, DAILY X21 DAYS, ORAL. During the same period patient was treated with VELCADE, DOXIL, PROTONIX, MARINOL, OXYCONTIN. Patient was hospitalized. Patient died on 02/09/2008.
Velcade Side Effects Report #5346825-X
VELCADE problem was reported by a Physician from AUSTRALIA on May 22, 2007. Male patient, 46 years of age, weighting 178.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: concomitant disease progression, fluid overload, leukaemia plasmacytic, plasmacytoma, renal failure, respiratory failure, . VELCADE dosage: unknown. Patient died on 01/17/2007.